🔎 Trials Near Me

Home › Multiple Myeloma › Oregon › Eugene

Multiple Myeloma clinical trials in Eugene, OR

6 studies for Multiple Myeloma are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Willamette Valley Cancer Institute and Research Center, Eugene
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07518186

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

RecruitingPhase 2
  • Willamette Valley Cancer Institute and Research Center, Eugene
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07637578

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 1
  • Willamette Valley Cancer Institute and Research Center /ID# 267088, Eugene
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05650632

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

RecruitingPhase 2
  • Oncology Associates of Oregon, Eugene
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT05972135

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecruitingPhase 1/2
  • Oncology Associates of Oregon, Eugene
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Eugene

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.